305 related articles for article (PubMed ID: 22142053)
1. Posttransplant lymphoproliferative disorder with lung involvement in a renal transplant recipient.
Mirza EI; Mutluay R; Suyani E; Okyay GU; Akyurek N; Aki SZ; Derici U; Arinsoy T
Exp Clin Transplant; 2011 Dec; 9(6):425-8. PubMed ID: 22142053
[TBL] [Abstract][Full Text] [Related]
2. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
3. Brain tumor as an unusual presentation of posttransplant lymphoproliferative disorder.
Azarpira N; Torabineghad S; Rakei M
Exp Clin Transplant; 2009 Mar; 7(1):58-61. PubMed ID: 19364315
[TBL] [Abstract][Full Text] [Related]
4. Detection of Epstein-Barr virus DNA in sequential renal transplant biopsy specimens using the polymerase chain reaction. Report of a patient with a posttransplant lymphoproliferative disorder.
Lager DJ; Slagel DD; Burgart LJ
Arch Pathol Lab Med; 1993 Mar; 117(3):308-12. PubMed ID: 8382918
[TBL] [Abstract][Full Text] [Related]
5. Multifocal cranial plasmablastic lymphoma as a rare manifestation of posttransplant lymphoproliferative disorder.
Jenabi A; Mooraki A; Jabbari M; Shayanfar N; Ghods AJ; Ziari MB; Bastani B
Iran J Kidney Dis; 2012 Sep; 6(5):380-5. PubMed ID: 22976265
[TBL] [Abstract][Full Text] [Related]
6. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: report of a case.
Shitrit D; Shitrit AB; Dickman R; Sahar G; Saute M; Kramer MR
Dis Colon Rectum; 2005 Nov; 48(11):2144-7. PubMed ID: 16086224
[TBL] [Abstract][Full Text] [Related]
8. CD20 antigen expression by lymphoproliferative disorders after kidney transplant is independently associated with a poor outcome: PTLD.Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2012 Aug; 10(4):325-31. PubMed ID: 22758374
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated lymphoproliferative disease in oral cavity in a renal transplant recipient: a case report.
Johnson J; Kerecuk L; Harrison M; Taylor JO; Odell E
Pediatr Transplant; 2007 May; 11(3):340-4. PubMed ID: 17430495
[TBL] [Abstract][Full Text] [Related]
10. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
11. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
[TBL] [Abstract][Full Text] [Related]
12. Novel treatment with rituximab of oropharyngeal posttransplant lymphoproliferative disorder after heart transplantation.
Kaczmarek I; Beiras-Fernandez A; Sadoni S; Bengel D; Deutsch MA; Meiser B; Reichart B
Exp Clin Transplant; 2005 Dec; 3(2):381-4. PubMed ID: 16417448
[TBL] [Abstract][Full Text] [Related]
13. Subacute immune response to primary EBV infection leading to post-transplant lymphoproliferative disease in a renal transplant patient.
Leaver S; Amlot P; Thuraisingham R; Norton A; Aitken C; Cavenagh JD
Clin Lab Haematol; 2004 Oct; 26(5):351-3. PubMed ID: 15485466
[TBL] [Abstract][Full Text] [Related]
14. Posttransplant lymphoproliferative disorder in the wall of a lymphocele: a case report.
Basic-Jukic N; Kes P; Coric M; Kastelan Z; Pasini J; Bubic-Filipi L
Transplant Proc; 2009 Jun; 41(5):1966-8. PubMed ID: 19545769
[TBL] [Abstract][Full Text] [Related]
15. Post-transplant lymphoproliferative disorder resembling Wilms tumor. Diagnostic dilemma: renal biopsy or nephrectomy?
Cheng E; Fustino N; Klesse L; Chinnakotla S; Sanghavi R
Pediatr Transplant; 2011 Dec; 15(8):E187-91. PubMed ID: 20670357
[TBL] [Abstract][Full Text] [Related]
16. Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.
Banks CA; Meier JD; Stallworth CR; White DR
Ann Otol Rhinol Laryngol; 2012 May; 121(5):291-5. PubMed ID: 22724273
[TBL] [Abstract][Full Text] [Related]
17. Posttransplant lymphoproliferative disorder: a pictorial review.
Burney K; Bradley M; Buckley A; Lyburn I; Rye A; Hopkins R
Australas Radiol; 2006 Oct; 50(5):412-8. PubMed ID: 16981935
[TBL] [Abstract][Full Text] [Related]
18. [Lymphoproliferative disorders after renal transplantation in a child].
Márquez U S; Peredo G MS; Vogel S A; Ibáñez A P
Rev Med Chil; 2009 Mar; 137(3):405-10. PubMed ID: 19621184
[TBL] [Abstract][Full Text] [Related]
19. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
[TBL] [Abstract][Full Text] [Related]
20. Case report: successful treatment of posttransplant lymphoproliferative disorder and quiescence of dermatomyositis with rituximab and sirolimus.
Kaposztas Z; Etheridge WB; Kahan BD
Transplant Proc; 2008 Jun; 40(5):1744-6. PubMed ID: 18589184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
